If you’re noticing memory slips and wondering whether something serious is going on, you’re not alone. The short answer: occasional forgetfulness is a normal part of aging, and the fact that you’re aware enough to search this question is itself a reassuring sign. But there are specific patterns that distinguish everyday memory lapses from early Alzheimer’s disease, and knowing what to look for can help you decide whether it’s time to see a doctor.
Normal Forgetfulness vs. Early Warning Signs
Everyone forgets things sometimes. Blanking on a name and remembering it later, making an occasional error when paying bills, or misplacing your keys and retracing your steps to find them are all typical parts of aging. These lapses don’t get progressively worse, and they don’t interfere with your ability to live independently.
Early Alzheimer’s looks different. The most common early sign is forgetting recently learned information: not just a name, but entire conversations or events from the past few days. You might ask the same question repeatedly without realizing you’ve already asked it. Important dates or appointments slip away entirely rather than coming back to you later. You find yourself increasingly relying on reminder notes, phone alarms, or family members for things you used to manage on your own.
Other warning signs go beyond memory. You might struggle to follow a familiar recipe you’ve made dozens of times, have trouble keeping track of monthly bills, or take much longer to complete routine tasks. Driving to a location you know well becomes confusing. You lose things and can’t retrace your steps to find them, sometimes even accusing others of moving or stealing your belongings. Tasks that require sequential steps, like making a cup of tea or organizing a grocery list, start to feel overwhelming.
The key distinction is pattern and progression. Normal aging produces isolated, occasional lapses. Early Alzheimer’s produces a steady decline that gets worse over months and begins to disrupt daily life.
Conditions That Mimic Alzheimer’s
Before jumping to the worst-case scenario, know that several treatable conditions cause memory and thinking problems that look remarkably like dementia. Depression is by far the most common. When someone is severely depressed, they may perform poorly on cognitive tests simply because of reduced effort and concentration, not because of brain degeneration. This is sometimes called pseudodementia, and it improves when the depression is treated.
Other reversible causes include an underactive thyroid, vitamin B12 deficiency, medication side effects, alcohol overuse, and even chronic sleep deprivation. Less common but still treatable causes include a buildup of fluid in the brain (normal pressure hydrocephalus), chronic infections, and slow-growing brain tumors. Standard workup for memory complaints includes blood tests for thyroid function and B12 levels, along with screening for depression. These are checked routinely precisely because they’re so often the real culprit.
What Happens During a Memory Evaluation
If you bring memory concerns to your doctor, the evaluation typically starts with a neurological exam. This checks your movement, coordination, reflexes, sensation, and balance. You might be asked to walk in a straight line, touch your finger to your nose with your eyes closed, or describe what you feel when different objects touch your skin. These tests help rule out other neurological conditions.
The cognitive portion is what most people think of. During a mental status exam, you’ll answer questions about the date, time, and where you are. You may be asked to remember a short list of items, name objects shown to you, repeat words, draw specific shapes, or count backward. Two widely used screening tools are the MMSE and the MoCA, both scored on a point scale. A score below 26 on the MoCA or below 24 on the MMSE generally flags possible cognitive impairment, though the cutoffs are adjusted based on your education level. These are screening tools, not diagnoses. A low score means further testing is warranted.
Brain imaging, usually an MRI, helps identify structural changes like shrinkage in brain areas associated with memory, or reveals other causes like tumors or fluid buildup. Blood work checks for thyroid problems, vitamin deficiencies, and other metabolic issues.
Blood Tests and Biomarkers
Alzheimer’s diagnosis has changed significantly. In 2024, the National Institute on Aging and the Alzheimer’s Association updated their diagnostic criteria to define Alzheimer’s by its underlying biology rather than symptoms alone. This means the disease can now be identified through biomarker tests that detect the specific proteins building up in the brain.
The FDA cleared the first blood test for Alzheimer’s diagnosis in 2025. It measures the ratio of two proteins in your blood: a form of tau protein (p-tau217) and a type of amyloid protein. In clinical studies of 499 cognitively impaired adults, 91.7% of people who tested positive on this blood test had confirmed amyloid plaques on a brain scan or spinal fluid test. Among those who tested negative, 97.3% were truly negative. This is a major step forward. Previously, confirming Alzheimer’s biology required either a PET scan of the brain or a spinal tap, both expensive and less accessible. The blood test is designed for adults 55 and older who are already showing signs of cognitive decline.
Genetic Risk Factors
A gene called APOE comes in several variants, and one version, APOE e4, is the strongest known genetic risk factor for late-onset Alzheimer’s. Carrying one copy of this variant doubles or triples your risk compared to the general population. Carrying two copies (one from each parent) increases the risk 8 to 12 times. But carrying the gene is not a diagnosis. Many people with one or even two copies of APOE e4 never develop Alzheimer’s, and many people who develop the disease don’t carry the variant at all.
Genetic testing for APOE e4 is available but isn’t routinely recommended for prediction purposes. It becomes more relevant if you’re considering one of the newer treatments, because carriers of this gene variant have a higher risk of certain side effects from those medications. Doctors are encouraged to check APOE e4 status before starting anti-amyloid therapy.
What Mild Cognitive Impairment Means
Many people searching “do I have Alzheimer’s” are actually experiencing something called mild cognitive impairment, or MCI. This is a middle ground: your memory or thinking abilities are worse than expected for your age, but not severe enough to interfere significantly with daily life. You can still live independently, manage your finances, and handle your routine, even if some tasks take more effort.
MCI does increase your risk of eventually developing Alzheimer’s. Roughly 10% to 25% of people with MCI progress to dementia each year. But this also means many people with MCI remain stable for years, and some actually return to normal cognitive function. An MCI diagnosis is not a guarantee of Alzheimer’s. It is, however, a reason to monitor your cognition regularly and address any reversible factors like depression, sleep problems, or medication effects.
Treatments Available Now
If testing does confirm early Alzheimer’s disease, treatment options have expanded. The FDA has approved antibody infusion therapies that target and remove amyloid plaques from the brain. These treatments are specifically for people in the early stages: those with mild cognitive impairment or mild dementia due to Alzheimer’s, with confirmed amyloid buildup in the brain. Confirmation requires either a PET scan, a spinal fluid test, or potentially the newer blood test.
These therapies slow cognitive decline rather than stopping or reversing it. Before starting treatment, you’ll need an MRI to establish a baseline, and your doctor will likely test for the APOE e4 gene because carriers face a higher risk of brain swelling or small bleeds as a side effect. Regular MRI monitoring continues throughout treatment.
What to Do With Your Concern
If your memory lapses are occasional, you can recall forgotten information later, and your daily functioning hasn’t changed, you’re most likely experiencing normal aging. Staying physically active, sleeping well, managing stress, and staying socially engaged are the strongest evidence-backed ways to protect your cognitive health over time.
If you’re noticing a pattern of worsening memory, difficulty with familiar tasks, confusion about time or place, or if family members have expressed concern, bring it up with your doctor. Early evaluation matters more now than it used to, because early-stage treatment options exist that weren’t available even five years ago. The diagnostic tools are faster, less invasive, and more accurate than before. Getting an answer, whatever it turns out to be, puts you in a position to act on it.